Advertisement

Lactic Acid Bacteria and Gut Health

  • Haitao LiEmail author
  • Zhifeng Fang
Chapter

Abstract

Over a century ago, the Nobel Laureate Elie Metchnikoff hypothesized that introducing lactic acid bacterium into the intestines might improve human health. The gut microbial dysbiosis has been implicated in several important gastrointestinal diseases. Epidemiological, clinical, and animal studies further provide evidence supporting the human health benefits of probiotics. This chapter provides an update on probiotic effects on gastrointestinal disorders and highlights possible challenges and opportunities to probiotic beyond tomorrow.

Keywords

Lactic acid bacteria (LAB) Gut microbiota Irritable bowel syndrome (IBS) Diarrhea Inflammatory bowel disease (IBD) colorectal cancer (CRC) 

References

  1. Agrawal A, Houghton LA, Morris J et al (2009) Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 29(1):104–114PubMedCrossRefPubMedCentralGoogle Scholar
  2. Ahl D, Liu H, Schreiber O et al (2016) Lactobacillus reuteri increases mucus thickness and ameliorates DSS-induced colitis in mice. Acta Physiol 217(4):300–310CrossRefGoogle Scholar
  3. Akin MA, Yikilmaz A, Gunes T et al (2014) Quantitative assessment of hepatic blood flow in the diagnosis and management of necrotizing enterocolitis. J Matern Fetal Neonatal Med 28(18):2160–2165PubMedCrossRefPubMedCentralGoogle Scholar
  4. Andrade MER, Araujo RS, de Barros PAV et al (2015) The role of immunomodulators on intestinal barrier homeostasis in experimental models. Clin Nutr 34(6):1080–1087PubMedCrossRefPubMedCentralGoogle Scholar
  5. Bäckhed F, Ley RE, Sonnenburg JL et al (2005) Host-bacterial mutualism in the human intestine. Science 307(5717):1915–1920PubMedCrossRefPubMedCentralGoogle Scholar
  6. Bäckhed F, Fraser CM, Ringel Y et al (2012) Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12(5):611–622PubMedCrossRefPubMedCentralGoogle Scholar
  7. Baert-Desurmont S, Charbonnier F, Houivet E et al (2016) Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk. Eur J Hum Genet 24(1):99–105PubMedCrossRefPubMedCentralGoogle Scholar
  8. Bajwa NM, Berner M, Worley S et al (2011) Population based age stratified morbidities of premature infants in switzerland. Swiss Med Wkly 141:w13212PubMedPubMedCentralGoogle Scholar
  9. Barberi C, Campana S, de Pasquale C et al (2015) T cell polarizing properties of probiotic bacteria. Immunol Lett 168(2):337–342PubMedCrossRefPubMedCentralGoogle Scholar
  10. Bengtsson J, Adlerberth I, Östblom A et al (2016) Effect of probiotics (Lactobacillus plantarum 299 plus bifidobacterium cure21) in patients with poor ileal pouch function: a randomised controlled trial. Scand J Gastroenterol 51(9):1–6CrossRefGoogle Scholar
  11. Bin-Nun A, Bromiker R, Wilschanski M et al (2006) Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 147(2):192–196CrossRefGoogle Scholar
  12. Bird AR, Conlon MA, Christophersen CT et al (2010) Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Benefic Microbes 1(4):423–431CrossRefGoogle Scholar
  13. Bischoff SC (2011) Gut health: a new objective in medicine? BMC Med 9:24PubMedPubMedCentralCrossRefGoogle Scholar
  14. Botteri E, Iodice S, Bagnardi V et al (2008) Smoking and colorectal cancer: a meta-analysis. JAMA 300(23):2765–2778PubMedCrossRefPubMedCentralGoogle Scholar
  15. Braga TD, Da SG, de Lira PI et al (2011) Efficacy of bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr 93(1):81–86PubMedCrossRefPubMedCentralGoogle Scholar
  16. Brenner H, Kloor M, Pox CP (2014a) Colorectal cancer. Lancet 383(9927):1490–1502PubMedCrossRefPubMedCentralGoogle Scholar
  17. Brenner H, Stock C, Hoffmeister M (2014b) Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 348(apr09 1):g2467PubMedPubMedCentralCrossRefGoogle Scholar
  18. Canani RB, Cirillo P, Terrin G et al (2007) Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 335(7615):1–6CrossRefGoogle Scholar
  19. Canfora EE, Jocken JW, Blaak EE (2015) Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11(10):577–591PubMedCrossRefPubMedCentralGoogle Scholar
  20. Castellarin M, Warren RL, Freeman JD et al (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22(2):299–306PubMedPubMedCentralCrossRefGoogle Scholar
  21. Chichlowski M, Rudolph C (2015) Visceral pain and gastrointestinal microbiome. J Neurogastroenterol Motil 21(2):172–181PubMedPubMedCentralCrossRefGoogle Scholar
  22. Chitapanarux I, Chitapanarux T, Traisathit P et al (2010) Research randomized controlled trial of live Lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 5:31PubMedPubMedCentralCrossRefGoogle Scholar
  23. Christensen JSR (2006) Aerococcus urinae. Apple Trees Productions, New YorkGoogle Scholar
  24. Chung EJ, Do EJ, Kim SY et al (2017) Combination of metformin and VSL#3 additively suppresses western-style diet induced colon cancer in mice. Eur J Pharmacol 794:1–7PubMedCrossRefPubMedCentralGoogle Scholar
  25. Cimperman L, Bayless G, Best K et al (2011) A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 45(9):785–789PubMedCrossRefPubMedCentralGoogle Scholar
  26. Ciorba MA, Riehl TE, Rao MS et al (2012). Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut 61(6):829–38.PubMedPubMedCentralCrossRefGoogle Scholar
  27. Collins SM (2014) A role for the gut microbiota in ibs. Nat Rev Gastroenterol Hepatol 11(8):497–505PubMedCrossRefPubMedCentralGoogle Scholar
  28. Corthesy B, Gaskins HR, Mercenier A (2006) Cross-talk between probiotic host immune system. J Nutr 137:781S–790SCrossRefGoogle Scholar
  29. Costeloe K, Hardy P, Juszczak E et al (2015) Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387(10019):649–660PubMedCrossRefPubMedCentralGoogle Scholar
  30. Costeloe K, Bowler U, Brocklehurst P et al (2016) A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: The probiotics in preterm infants (pips) trial. Health Technol Assess 20(66):1–194PubMedPubMedCentralCrossRefGoogle Scholar
  31. Cotten CM, Taylor S, Stoll B et al (2009) Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123(1):58–66PubMedPubMedCentralCrossRefGoogle Scholar
  32. Courtney J, Liebelt D, Nett MP et al (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6(11):e280CrossRefGoogle Scholar
  33. Crockett SD, Long MD, Dellon ES et al (2011) Inverse relationship between moderate alcohol intake and rectal cancer: analysis of the north carolina colon cancer study. Dis Colon Rectum 54(7):887–894PubMedPubMedCentralCrossRefGoogle Scholar
  34. Cummings CJSSP (2015) Gut bacteria and necrotizing enterocolitis cause or effect. Trends Microbiol 23(6):332–333PubMedCrossRefGoogle Scholar
  35. Dani C, Biadaioli R, Bertini G et al (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. Biol Neonate 82(2):103–108PubMedCrossRefGoogle Scholar
  36. Declercq V, Mcmurray DN, Chapkin RS (2015) Obesity promotes colonic stem cell expansion during cancer initiation. Cancer Lett 369(2):336–343PubMedPubMedCentralCrossRefGoogle Scholar
  37. Demirel G, Erdeve O, Celik IH et al (2013) Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study. Acta Paediatr 102(12):e560–e565PubMedCrossRefGoogle Scholar
  38. Derrien M, van Hylckama Vlieg JET (2015) Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol 23(6):354–366PubMedCrossRefGoogle Scholar
  39. Dethlefsen L, Gordon JI (2011) Colloquium paper: incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108(Suppl 1):4554–4561PubMedCrossRefGoogle Scholar
  40. Didari T, Mozaffari S, Nikfar S et al (2015) Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J Gastroenterol 21(10):3072–3084PubMedPubMedCentralCrossRefGoogle Scholar
  41. Dilli D, Aydin B, Fettah ND et al (2015) The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. J Pediatr 166(3):545–551PubMedCrossRefGoogle Scholar
  42. Dinleyici EC, Vandenplas Y (2014) Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatr 103(7):e300PubMedGoogle Scholar
  43. Dinleyici EC, Eren M, Ozen M et al (2012) Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 12(4):395–410PubMedCrossRefGoogle Scholar
  44. Dinleyici EC, Cagri E, Dalgic N et al (2013) The effect of a multispecies synbiotic mixture on the duration of diarrhea and length of hospital stay in children with acute diarrhea in turkey: Single blinded randomized study. Eur J Pediatr 172(4):459–464PubMedCrossRefGoogle Scholar
  45. Dinleyici EC, Dalgic N, Guven S et al (2015) Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. J Pediatr 91(4):392–396CrossRefGoogle Scholar
  46. Faith JJ, Guruge JL, Mark C et al (2013) The long-term stability of the human gut microbiota. Science 341(6141):1237439PubMedPubMedCentralCrossRefGoogle Scholar
  47. Fedirko V, Tramacere I, Bagnardi V et al (2011) Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol 22(9):1958–1972PubMedCrossRefGoogle Scholar
  48. Fernándezcarrocera LA (2013) Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 98(1):F5–F9CrossRefGoogle Scholar
  49. Fleming P, Hall NJ, Eaton S (2015) Probiotics and necrotizing enterocolitis. Pediatr Surg Int 31:1111–1118PubMedCrossRefPubMedCentralGoogle Scholar
  50. Flint HJ, Duncan SH, Scott KP et al (2015) Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc 74(1):13–22PubMedCrossRefPubMedCentralGoogle Scholar
  51. Floch MH, Walker WA, Madsen K et al (2011) Recommendations for probiotic use-2011 update. J Clin Gastroenterol 45(Suppl):S168–S171PubMedCrossRefPubMedCentralGoogle Scholar
  52. Furrie E (2005) Synbiotic therapy (Bifidobacterium longum/synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54(2):242–249PubMedPubMedCentralCrossRefGoogle Scholar
  53. Gallagher EJ, LeRoith D (2011) Minireview: Igf, insulin, and cancer. Endocrinology 152(7):2546–2551PubMedCrossRefPubMedCentralGoogle Scholar
  54. Gareau MG, Sherman PM, Walker WA (2010) Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7(9):503–514PubMedPubMedCentralCrossRefGoogle Scholar
  55. Gerard P (2016) Gut microbiota and obesity. Cell Mol Life Sci 73(1):147–162PubMedCrossRefGoogle Scholar
  56. Germansky KA, Leffler DA (2011) Best practice & research clinical gastroenterology. Best Pract Res Clin Gastroenterol 25:387–395PubMedCrossRefGoogle Scholar
  57. Gianotti L, Morelli L, Galbiati F et al (2010) A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol 16(2):167–175PubMedPubMedCentralCrossRefGoogle Scholar
  58. Gorelnikova EA, Karpunina LV (2015) Effect of lactobacilli exopolysaccharides on phagocyte and cytokine activity in vitro and in animal organism during infectious process modeling. Zhurnal Mikrobiologii Epidemiologii Immunobiologii 2015(5):44–50Google Scholar
  59. Guarner F, Sanders ME, Gibson G et al (2011) Probiotic and prebiotic claims in europe: Seeking a clear roadmap. Br J Nutr 106(11):1765–1767PubMedCrossRefPubMedCentralGoogle Scholar
  60. Guglielmetti S, Mora D, Gschwender M et al (2011) Randomised clinical trial: Bifidobacterium bifidum MIMBB75 significantly alleviates irritable bowel syndrome and improves quality of life —a double-blind, placebo-controlled study. Aliment Pharmacol Ther 33(10):1123–1132PubMedCrossRefPubMedCentralGoogle Scholar
  61. Gutierrez-Castrellon P, Lopez-Velazquez G, Diaz-Garcia L et al (2014) Diarrhea in preschool children and lactobacillus reuteri: a randomized controlled trial. Pediatrics 133(4):904–909CrossRefGoogle Scholar
  62. Guyonnet D, Chassany O, Ducrotte P et al (2007) Effect of a fermented milk containing bifidobacterium animalis dn-173010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 26(3):475–486PubMedCrossRefPubMedCentralGoogle Scholar
  63. Han C, Shin A, Lee J et al (2015) Dietary calcium intake and the risk of colorectal cancer: a case control study. BMC Cancer 15(1):1–11CrossRefGoogle Scholar
  64. Hannan LM, Jacobs EJ, Thun MJ (2009) The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the united states. Cancer Epidemiol Biomark Prev 18(12):3362–3367CrossRefGoogle Scholar
  65. Harald M, Thomas K, Manfred G et al (2010) Clinical trial: Probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917(EcN). BMC Complement Altern Med 10(1):1–8CrossRefGoogle Scholar
  66. Hardy H, Harris J, Lyon E et al (2013) Probiotics, prebiotics and immunomodulation of gut mucosal defences homeostasis and immunopathology. Nutrients 5:1869–1912PubMedPubMedCentralCrossRefGoogle Scholar
  67. Hegar B, Waspada IM, Gunardi H et al (2015) A double blind randomized trial showing probiotics to be ineffective in acute diarrhea in indonesian children. Indian J Pediatrics 82(5):410–414CrossRefGoogle Scholar
  68. Hevia A, Delgado S, Sanchez B et al (2015) Molecular players involved in the interaction between beneficial bacteria and the immune system. Front Microbiol 6:1285PubMedPubMedCentralCrossRefGoogle Scholar
  69. Hojsak I, Abdovic S, Szajewska H et al (2010) Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 125:e1171–e1177PubMedCrossRefPubMedCentralGoogle Scholar
  70. Hojsak I, Tokić PV, Močić PA et al (2015) Bifidobacterium animalis subsp. lactis fails to prevent common infections in hospitalized children: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr 101(3):680–684PubMedCrossRefPubMedCentralGoogle Scholar
  71. Hooper LV, Midtvedt T, Gordon JI (2002) How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22(1):283–307PubMedCrossRefPubMedCentralGoogle Scholar
  72. Hugenholtz J, Smid EJ (2002) Nutraceutical production with food-grade microorganisms. Curr Opin Biotechnol 13:497–507PubMedCrossRefPubMedCentralGoogle Scholar
  73. Ishikawa H, Akedo I, Otani T et al (2005) Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer 116(5):762–767PubMedCrossRefPubMedCentralGoogle Scholar
  74. Islek A, Sayar E, Yilmaz A et al (2014) The role of Bifidobacterium lactis b94 plus inulin in the treatment of acute infectious diarrhea in children. Turk J GastroenterolOff J Turk Soc Gastroenterol 25(6):628–633CrossRefGoogle Scholar
  75. Kabeerdoss P, Jayakanthan J, Pugazhendhi S et al (2015) Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid. Indian J Med Res 142:23–32PubMedPubMedCentralGoogle Scholar
  76. Kajander K, Myllyluoma E, Rajili M et al (2008) Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 27(1):48–57PubMedCrossRefPubMedCentralGoogle Scholar
  77. Kato K, Mizuno S, Umesaki Y et al (2004) Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther 20:1133–1141PubMedCrossRefPubMedCentralGoogle Scholar
  78. Kianifar H, Jafari SA, Kiani M et al (2015) Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electron Physician 7(5):1255–1260PubMedPubMedCentralGoogle Scholar
  79. Kitazawa H, Alvarez S, Suvorov A et al (2015) Recent advances and future perspective in microbiota and probiotics. Biomed Res Int 2015:1–2CrossRefGoogle Scholar
  80. Klein M, Sanders ME, Duong T et al (2010) Probiotics: from bench to market. Ann N Y Acad Sci 1212(Suppl 1):E1–E14PubMedPubMedCentralCrossRefGoogle Scholar
  81. Kotzampassi K, Stavrou G, Damoraki G et al (2015) A four-probiotics regimen reduces postoperative complications after colorectal surgery: a randomized, double-blind, placebo-controlled study. World J Surg 39(11):2776–2783PubMedCrossRefPubMedCentralGoogle Scholar
  82. Lee JY, Chu SH, Jeon JY et al (2014) Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial. Dig Liver Dis 46(12):1126–1132PubMedCrossRefPubMedCentralGoogle Scholar
  83. Lenoir M (2016) Lactobacillus casei BL23 regulates Treg and Th17 t-cell populations and reduces DMH-associated colorectal cancer. J Gastroenterol 51(9):1–12CrossRefGoogle Scholar
  84. Leu RKL (2010) Synbiotic intervention of bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31(2):246–251PubMedCrossRefPubMedCentralGoogle Scholar
  85. Levesque BG, Sandborn WJ, Ruel J et al (2015) Converging goals of treatment of inflammatory bowel disease from clinical trials and practice. Gastroenterology 148(1):37–51PubMedCrossRefPubMedCentralGoogle Scholar
  86. Lim JC, Golden JM, Ford HR (2015) Pathogenesis of neonatal necrotizing enterocolitis. Pediatr Surg Int 31(6):509–518PubMedCrossRefPubMedCentralGoogle Scholar
  87. Lin HC, Hsu CH, Chen HL et al (2008) Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122(4):693–700PubMedCrossRefPubMedCentralGoogle Scholar
  88. Liu Z, Qin H, Yang Z et al (2011) Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery—a double-blind study. Aliment Pharmacol Ther 33(1):50–63PubMedCrossRefPubMedCentralGoogle Scholar
  89. Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12(10):661–672PubMedCrossRefPubMedCentralGoogle Scholar
  90. Ma EL, Choi YJ, Choi J et al (2010) The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. Int J Cancer 127(4):780–790PubMedPubMedCentralGoogle Scholar
  91. Maccaferri S, Klinder A, Cacciatore S et al (2012) In vitro fermentation of potential prebiotic flours from natural sources: Impact on the human colonic microbiota and metabolome. Mol Nutr Food Res 56(8):1342–1352PubMedCrossRefPubMedCentralGoogle Scholar
  92. Macfarlane S, Macfarlane GT, Cummings JH (2006) Review article prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 24:701–714PubMedCrossRefPubMedCentralGoogle Scholar
  93. Mai V, Young CM, Ukhanova M et al (2011) Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One 6(6):e20647PubMedPubMedCentralCrossRefGoogle Scholar
  94. Marteau P, Lémann M, Seksik P et al (2006) Ineffectiveness of Lactobacillus johnsonii La1 for prophylaxis of postoperative recurrence in crohn’s disease: a randomised, double blind, placebo controlled GETAID trial. Gut 55(6):842–847PubMedPubMedCentralCrossRefGoogle Scholar
  95. Martinez-Augustin O, Rivero-Gutierrez B, Mascaraque C et al (2014) Food derived bioactive peptides and intestinal barrier function. Int J Mol Sci 15(12):22857–22873PubMedPubMedCentralCrossRefGoogle Scholar
  96. Mazurak N, Broelz E, Storr M et al (2015) Probiotic therapy of the irritable bowel syndrome: why is the evidence still poor and what can be done about it? J Neurogastroenterol Motil 21(4):471–485PubMedPubMedCentralCrossRefGoogle Scholar
  97. Meini S, Laureano R, Fani L et al (2015) Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature. Infection 43(6):777–781PubMedCrossRefPubMedCentralGoogle Scholar
  98. Mercado-Lubo R, McCormick BA (2010) A unique subset of peyer’s patches express lysozyme. Gastroenterology 138(1):36–39PubMedCrossRefPubMedCentralGoogle Scholar
  99. Moayyedi P, Ford AC, Talley NJ et al (2010) The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59(3):325–332PubMedCrossRefPubMedCentralGoogle Scholar
  100. Moreno de LeBlanc A, Perdigón G (2010) The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc 69(3):421–428PubMedCrossRefPubMedCentralGoogle Scholar
  101. Nabi G, Hummaida TI, Saidy KM (2006) Necrotizing enterocolitis in a very low birth weight (VLBW). JK-Practitioner 13:100–102Google Scholar
  102. Neu J, Walker WA (2011) Medical progress: necrotizing enterocolitis. N Engl J Med 364(3):255–264PubMedPubMedCentralCrossRefGoogle Scholar
  103. Ng SC, Plamondon S, Kamm MA et al (2010) Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis. Inflamm Bowel Dis 16(8):1286–1298PubMedCrossRefPubMedCentralGoogle Scholar
  104. Niemarkt HJ, de Meij TGJ, van de Velde ME et al (2015) Necrotizing enterocolitis: a clinical review on diagnostic biomarkers and the role of the intestinal microbiota. Inflamm Bowel Dis 21(2):436–444PubMedCrossRefPubMedCentralGoogle Scholar
  105. Nobaek S, Johansson ML, Molin G et al (2000) Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95(5):1231–1238PubMedCrossRefPubMedCentralGoogle Scholar
  106. O’Mahony L, Mccarthy J, Kelly P et al (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128(3):541–551PubMedCrossRefPubMedCentralGoogle Scholar
  107. Odegaard AO, Koh WP, Yu MC et al (2011) Body mass index and risk of colorectal cancer in chinese singaporeans. Cancer 117(16):3841–3849PubMedPubMedCentralCrossRefGoogle Scholar
  108. Owaga E, Hsieh RH, Mugendi B et al (2015) Th17 cells as potential probiotic therapeutic targets in inflammatory bowel diseases. Int J Mol Sci 16(9):20841–20858PubMedPubMedCentralCrossRefGoogle Scholar
  109. Pajares JA, Perea J (2015) Multiple primary colorectal cancer: individual or familial predisposition? World J Gastrointest Oncol 7(12):434–444PubMedPubMedCentralCrossRefGoogle Scholar
  110. Pala V, Sieri S, Berrino F et al (2011) Yogurt consumption and risk of colorectal cancer in the italian european prospective investigation into cancer and nutrition cohort. Int J Cancer 129(11):2712–2719PubMedCrossRefPubMedCentralGoogle Scholar
  111. Palmer C, Bik EM, Digiulio DB et al (2007) Development of the human infant intestinal microbiota. PLoS Biol 5(7):e177PubMedPubMedCentralCrossRefGoogle Scholar
  112. Pearson JR, Gill CI, Rowland IR (2009) Diet, fecal water, and colon cancer-development of a biomarker. Nutr Rev 67(9):509–526PubMedCrossRefPubMedCentralGoogle Scholar
  113. Patrick MD, Thomas J, Kim IS et al (2014) The art of strain improvement of industrial lactic acid bacteria without the use of recombinant DNA technology. Microb Cell Fact 13 Suppl 1(1):1–13Google Scholar
  114. Quigley EM (2013) Gut bacteria in health and disease. Gastroenterol Hepatol 9(9):560–569Google Scholar
  115. Rafter J (2002) Lactic acid bacteria and cancer: mechanistic perspective. Br J Nutr 88(S1):S89–S94PubMedCrossRefPubMedCentralGoogle Scholar
  116. Rafter J, Bennett M, Caderni G et al (2007) Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85(2):488–496PubMedCrossRefPubMedCentralGoogle Scholar
  117. Raufman JP, Dawson PA, Rao A et al (2015) Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids. Carcinogenesis 36(10):1193–1200PubMedPubMedCentralCrossRefGoogle Scholar
  118. Reali A, Greco F, Marongiu G et al (2015) Individualized fortification of breast milk in 41 extremely low birth weight (ELBW) preterm infants. Clin Chim Acta 451:107–110PubMedCrossRefPubMedCentralGoogle Scholar
  119. Rowland IR (2009) The role of the gastrointestinal microbiota in colorectal cancer. Curr Pharm Des 15(13):1524–1527PubMedCrossRefPubMedCentralGoogle Scholar
  120. Rowland I, Rumney C, Coutts J et al (1998) Effect of bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19(2):281–285PubMedCrossRefPubMedCentralGoogle Scholar
  121. Roy CC, Kien CL, Bouthillier L et al (2006) Short-chain fatty acids: ready for prime time? Nutr Clin Pract 21(4):351–366PubMedCrossRefPubMedCentralGoogle Scholar
  122. Saad N, Delattre C, Urdaci M et al (2013) An overview of the last advances in probiotic and prebiotic field. LWT-Food Sci Technol 50(1):1–16CrossRefGoogle Scholar
  123. Saavedra J (2000) Probiotics and infectious diarrhea. Am J Gastroenterol 95(Supp. l):S16–S18PubMedCrossRefPubMedCentralGoogle Scholar
  124. Saavedra JM, Bauman NA, Oung I et al (1994) Feeding of bifidobacterium bifidum and streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344(8929):1046–1049PubMedCrossRefPubMedCentralGoogle Scholar
  125. Sanders ME, Levy DD (2011) The science and regulations of probiotic food and supplement product labeling. Ann N Y Acad Sci 1219(s1):E1–E23PubMedCrossRefPubMedCentralGoogle Scholar
  126. Sanders ME, Guarner F, Guerrant R et al (2013) An update on the use and investigation of probiotics in health and disease. Gut 62(5):787–796PubMedPubMedCentralCrossRefGoogle Scholar
  127. Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620–1633PubMedCrossRefPubMedCentralGoogle Scholar
  128. Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134(2):577–594PubMedCrossRefPubMedCentralGoogle Scholar
  129. Scott KP, Gratz SW, Sheridan PO et al (2013) The influence of diet on the gut microbiota. Pharmacol Res 69(1):52–60PubMedCrossRefPubMedCentralGoogle Scholar
  130. Sears CL, Pardoll DM (2011) Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J Infect Dis 203(3):306–311PubMedPubMedCentralCrossRefGoogle Scholar
  131. Shanahan F, Collins SM (2010) Pharmabiotic manipulation of the microbiota in gastrointestinal disorders, from rationale to reality. Gastroenterol Clin N Am 39(3):721–726CrossRefGoogle Scholar
  132. Sharma D, Shastri S (2016) Lactoferrin and neonatology-role in neonatal sepsis and necrotizing enterocolitis: present, past and future. J Matern Fetal Neonatal Med 29(5):763–770PubMedCrossRefPubMedCentralGoogle Scholar
  133. Simrén M, Öhman L, Olsson J et al (2010) Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome-a randomized, double-blind, controlled study. Aliment Pharmacol Ther 31(2):218–227PubMedGoogle Scholar
  134. Sivan A, Corrales L, Hubert N et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350(6264):1084–89PubMedPubMedCentralCrossRefGoogle Scholar
  135. Soares RL (2014) Irritable bowel syndrome: a clinical review. World J Gastroenterol 20(34):12144–12160PubMedPubMedCentralCrossRefGoogle Scholar
  136. Steed H, Macfarlane GT, Blackett KL et al (2010) Clinical trial: the microbiological and immunological effects of symbiotic consumption-a randomized double-blind placebo-controlled study in active crohn’s disease. Aliment Pharmacol Ther 32(7):872–883PubMedCrossRefPubMedCentralGoogle Scholar
  137. Stevenson C, Blaauw R, Fredericks E et al (2014) Randomized clinical trial: effect of Lactobacillus plantarum 299v on symptoms of irritable bowel syndrome. Nutrition 30(10):1151–1157PubMedCrossRefPubMedCentralGoogle Scholar
  138. Stolaki M, de Vos W M, Kleerebezem M, et al (2012) Lactic acid bacteria in the gut. In: Lactic acid bacteria: microbiology and functional aspects, pp 385–401CrossRefGoogle Scholar
  139. Szajewska H, Kolodziej M (2015) Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther 42(10):1149–1157CrossRefGoogle Scholar
  140. Szajewska H, Ruszczynski M, Radzikowski A (2006) Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trials. J Pediatr 149:367–372PubMedCrossRefPubMedCentralGoogle Scholar
  141. Takeda KOK (2009) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr 137:791S–793SCrossRefGoogle Scholar
  142. Takiishi T, Korf H, van Belle TL et al (2012) Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J Clin Invest 122(5):1717–1725PubMedPubMedCentralCrossRefGoogle Scholar
  143. Tursi A, Brandimarte G, Papa A et al (2010) Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 105(10):2218–2227PubMedPubMedCentralCrossRefGoogle Scholar
  144. Vandenplas Y, Veereman-Wauters G, Greef ED et al (2011) Probiotics and prebiotics in prevention and treatment of diseases in infants and children. J Pediatr 87(4):292–300CrossRefGoogle Scholar
  145. Vétizou M, Pitt JM, Daillère R et al (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350(6264):1079–84PubMedPubMedCentralCrossRefGoogle Scholar
  146. Vlieg JEVH, Veiga P, Zhang C et al (2011) Impact of microbial transformation of food on health-from fermented foods to fermentation in the gastro-intestinal tract. Curr Opin Biotechnol 22(2):211–219CrossRefGoogle Scholar
  147. Wani MA, Jan FA, Khan NA et al (2014) Cancer trends in kashmir: common types, site incidence and demographic profiles: National cancer registry 2000–2012. Indian J Cancer 51(2):133–137PubMedCrossRefPubMedCentralGoogle Scholar
  148. Weichert S, Schroten H, Adam R (2012) The role of prebiotics and probiotics in prevention and treatment of childhood infectious diseases. Pediatr Infect Dis J 31(8):859–862PubMedCrossRefGoogle Scholar
  149. Whorwell PJ, Altringer L, Morel J et al (2006) Efficacy of an encapsulated probiotic bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101(7):1581–1590PubMedCrossRefGoogle Scholar
  150. Wildt S, Nordgaard I, Hansen U et al (2011) A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus la-5 and Bifidobacterium animalis subsp. lactis bb-12 for maintenance of remission in ulcerative colitis. J Crohns Colitis 5(2):115–121PubMedCrossRefGoogle Scholar
  151. Williams EA, Stimpson J, Wang D et al (2009) Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther 29(1):97–103PubMedCrossRefGoogle Scholar
  152. Worthley DL, Leu RKL, Whitehall VL et al (2009) A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 90(3):578–586PubMedCrossRefGoogle Scholar
  153. Yazar AS, Güven Ş, Dinleyici EÇ (2016) Effects of zinc or synbiotic on the duration of diarrhea in children with acute infectious diarrhea. Turk J Gastroenterol Off J Turk Soc Gastroenterol 27(6):537–540CrossRefGoogle Scholar
  154. Zani A, Pierro A (2015) Necrotizing enterocolitis controversies and challenges. F1000 Research 4:1–10CrossRefGoogle Scholar
  155. Zeng J, Li YQ, Zuo XL et al (2008) Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 28(8):994–1002PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and Science Press 2019

Authors and Affiliations

  1. 1.Jiangnan UniversityWuxiChina

Personalised recommendations